Key Takeaways
- PAT up 63% YoY, driven by lower impairments: Consolidated profit after tax rose sharply as impairment charges on loans fell, not because of an operating lift.
- GI premium growth sprinted at 1.9x the industry: Gross written premium grew 43.3% YoY, but management expects this pace to moderate to 1.5–1.6x industry growth by year-end as base effects kick in.
- A regulatory shift is compressing near-term insurance profits: A new IRDA directive forces upfront expensing of all acquisition costs on long-term policies, hurting the P&L now while building embedded value for later.
- Motor third-party claims just got a structural reset: The Motor Vehicles Act now mandates claim intimation within six months, a change management believes will slash the historic uncertainty in TP loss provisioning.
- What to watch next quarter: Whether the October deadline for the first claims under the new six-month rule brings a clear market signal on TP loss ratios, and how quickly motor own-damage loss ratios normalize as CV business restores.
The Long-Term Policy Accounting Shock
- The mechanics of the hit: Per a new IRDA directive, the entire acquisition cost on long-term policies must be expensed upfront in the quarter the policy is written, while the earnings from those policies accrue over multiple years. This creates a P&L drag today and builds embedded value on the balance sheet.
- Why the pain is amplified right now: The share of long-term embedded GWP jumped from 5% in Q1 FY22 to 10.6% in Q1 FY23, driven by growth in dwellings and health benefit products, so the volume of costs absorbed upfront is materially higher.
- The mix will self-correct, partly: Q1 is a seasonally lean quarter for motor, which is predominantly annual; as motor volumes swell over the remaining nine months, the long-term share is expected to drop to about 8.5% by year-end.
- Management is not backing away: The stated intent is to maintain a high proportion of profitably long-term lines like dwelling, personal accident, and health benefit because they are inherently and economically profitable, even if they hurt this year’s financials.
V. Suryanarayanan: “...it is pure economic benefits it may hurt this year's financials but the value that you are building in the balance sheet will be much stronger.”
Motor Insurance: The TP Inflection and OD Pressure
- The Motor Vehicles Act game-changer: The Act now sets a strict six-month time limit from the date of accident for claim intimation, and courts’ power to condone delayed filings has been removed. Historically, motor third-party claims could be reported up to seven years later, creating extreme provisioning uncertainty. The Kerala High Court and, in a veiled way, the Supreme Court have affirmed this change.
- What it means for provisioning: Management is waiting for actual market implementation before asking actuarial teams to revisit TP provisioning ratios, so the current 78% loss ratio does not yet factor in any benefit from the new rule. The first claim under the new timeline has until October 2022 to be reported, so a clear market signal is expected by October end or November.
- The trade-off: Faster claim settlement means cash outflow will accelerate, which will affect investment leverage even as provisioning uncertainty falls.
- Own-damage loss ratio remains elevated: The OD loss ratio moderated from Q4’s 82.8% but stays under pressure from both premium discounting and a 4–6% rise in OEM labour charges and parts prices, an inflationary effect management expects to continue.
- The CV restoration lever: Commercial vehicle business, sourced via financier tie-ups, is slowly restoring and will have a positive effect on the OD loss ratio when it does, because CVs carry lower opex pressure than cars and two-wheelers.
V. Suryanarayanan: “...the single most important one, is the time limit for intimation of a motor accident claim, which is now placed clearly at six months from the date of the accident. motor third party accident claims, typically and historically has had a practice of getting reported even up to seven years which brought out a high level of uncertainty.”
Growth Trajectory and Diversification
- Q1 was an outlier, not the new normal: The 43.3% YoY GWP growth, at 1.9x industry growth excluding SAHI, was flattered by a lockdown-depressed base in Q1 last year. Management expects full-year growth to settle at 1.5 to 1.6x industry growth.
- The portfolio is deliberately shifting away from motor: Motor’s share fell from 51% to 46% in the commercial vehicle segment, while two-wheeler and passenger car shares rose. The conscious strategy is to grow personal accident, retail health, and property lines at a faster clip to de-risk from motor.
- New channels are doing the work: Volume from new channels, new verticals, OEM tie-ups, and financial channels posted very good growth, and the share of premium from Chola Finance plus own outlets is expected to rise from ~31% to at least 35% by year-end.
- Reinsurance capacity is a competitive unlock: Enhanced reinsurance capacities, earned through profitability delivered to reinsurers, now position Chola MS to compete more aggressively for larger property insurance businesses.
V. Suryanarayanan: “I would tend to think that by end of the year, we would be at about 1.5 to 1.6X of GI growth, I think that is the kind of growth that we expect and as I said earlier, our own emphasis in property and the other lines will be larger given our conscious bid to diversify and de-risk from motor.”
Expense Ratios: Why the Peer Comparison Breaks
- The opex ratio is structurally higher, and management says that is by design: Strict comparison with industry players is not appropriate because many peers have large proportions of crop business, employer/employee group health, and government health business, all of which carry very low acquisition costs due to tender-based distribution or inherently high loss ratios. Chola MS has only marginal presence in these segments.
- Group health is deliberately avoided: The company does not write group health business extensively as a matter of board policy, citing the volatility and adverse loss ratios in that segment. Q1 group health volume was only ~₹36 Crores out of ₹1,290 Crores GWP.
- Promotional spend added to the Q1 burden: Advertisement and sales promotion expenses rose on a combination of absolute volume accretion (₹400 Crores QoQ), a higher proportion of long-term business, and specific branding spends including the RCB IPL association, Delhi metro, and FM radio campaigns.
- The cost ratio should find its level: As the full-year growth rate moderates from the Q1 sprint and the annual portion of the book starts reflecting in earnings, the cost ratios will naturally moderate.
V. Suryanarayanan: “...strict comparison with the industry players may not be appropriate considering that many of them have a larger proportion of crop business or employer/employee group health business and government health business. All these businesses are either on tender basis or because of the inherent high loss ratios that these businesses have, they have very low acquisition cost...”
Investment Book: Rising Yields Meet a Short-Duration Advantage
- The repo rate tailwind is real: RBI repo rate increases have resulted in a substantial improvement in yield on fresh investment deployment, and in July, post the latest rate revision, incremental investments were deployed at an even higher yield.
- The short-duration shield: The investment book carries a low duration of 3.6 years, which reduces interest rate risk and creates a steady opportunity to reinvest maturing proceeds at higher yields. The FD strategy, with over 10% of AUM in instruments maturing within one year, has been deliberately positioned to capture the rising-rate environment.
- The MTM offset: While fresh deployment yields are rising, the mark-to-market value of the existing book is negative, so there is less opportunity for profit booking from the sale of debt securities this year compared to last.
- Management declined to give a yield forecast: When asked for expected investment yield for FY23 and FY24 under a flat-rate scenario, management stated the number can be calculated mathematically from information already provided and declined to offer a directional figure.
- Equity allocation is rising slowly: The equity book is expected to grow to 4–5% of the total corpus over the next two years.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Full-year GI growth | 1.5 to 1.6x of industry growth | FY23 year-end |
| Long-term premium mix | Decline from 10.6% to ~8.5% of GWP | FY23 year-end |
| Chola Finance + own outlet premium share | Rise from ~31% to at least 35% | FY23 year-end |
| ROE | 12.5% to 13% range | FY23 year-end |
| Motor TP provisioning review | Actuarial teams to relook at ratios once MVA benefits actually pan out | After market implementation observed |
| Equity book allocation | Grow to 4–5% of corpus | Over next two years |
| Motor TP claim reporting clarity | First claim under new six-month rule reportable by October 2022; clear indication expected | October end / November 2022 |
Key Metrics
| Metric | Q1 FY23 |
|---|---|
| Consolidated total income | ₹3,963 cr, +10% YoY |
| Consolidated profit after tax | ₹582 cr, +63% YoY, primarily due to reduction in impairment charges on loans |
| Standalone total income | ₹2.10 cr vs ₹2.12 cr in Q1 FY22 |
| Standalone loss | ₹0.26 cr vs ₹0.93 cr in Q1 FY22 |
| Chola MS GWP | ₹1,292 cr, +43.3% YoY |
| Chola MS growth vs industry | 1.9x of industry growth excluding SAHI players |
| Management internal ROE estimate for FY23 | 12.5% to 13% |
| Investment yield | ~6.2%, broadly unchanged QoQ |
| Investment leverage | ~6.5x, one of the highest in the industry |
| Average investment duration | ~3.6 years |
| Motor portfolio share | 61% of portfolio, grew 35% YoY |
| Motor OD loss ratio | Moderated from Q4 level of 82.8% but remains elevated |
| Motor TP loss ratio | 78%, without considering Motor Vehicle Act benefits |
| Long-term policies embedded GWP share | 10.6%, up from 5% in Q1 FY22; expected to moderate to ~8.5% by year-end |
| Health indemnity renewals | ~70% by number of policies |
| Premium from Chola Finance and own insurance express outlets | ~31% of total premium |